BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24814803)

  • 21. Proton magnetic resonance metabolomic characterization of ovarian serous carcinoma effusions: chemotherapy-related effects and comparison with malignant mesothelioma and breast carcinoma.
    Vettukattil R; Hetland TE; Flørenes VA; Kærn J; Davidson B; Bathen TF
    Hum Pathol; 2013 Sep; 44(9):1859-66. PubMed ID: 23656974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions.
    Slipicevic A; Øy GF; Askildt IC; Holth A; Hellesylt E; Flørenes VA; Davidson B
    Hum Pathol; 2009 Apr; 40(4):527-37. PubMed ID: 19121847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and clinical role of antiapoptotic proteins of the bag, heat shock, and Bcl-2 families in effusions, primary tumors, and solid metastases in ovarian carcinoma.
    Elstrand MB; Kleinberg L; Kohn EC; Tropé CG; Davidson B
    Int J Gynecol Pathol; 2009 May; 28(3):211-21. PubMed ID: 19620938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
    Davidson B; Hadar R; Stavnes HT; Trope' CG; Reich R
    Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mammalian target of rapamycin is a biomarker of poor survival in metastatic serous ovarian carcinoma.
    Bunkholt Elstrand M; Dong HP; Ødegaard E; Holth A; Elloul S; Reich R; Tropé CG; Davidson B
    Hum Pathol; 2010 Jun; 41(6):794-804. PubMed ID: 20153512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma.
    Elloul S; Elstrand MB; Nesland JM; Tropé CG; Kvalheim G; Goldberg I; Reich R; Davidson B
    Cancer; 2005 Apr; 103(8):1631-43. PubMed ID: 15742334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Class III β-tubulin expression in advanced-stage serous ovarian carcinoma effusions is associated with poor survival and primary chemoresistance.
    Hetland TE; Hellesylt E; Flørenes VA; Tropé C; Davidson B; Kærn J
    Hum Pathol; 2011 Jul; 42(7):1019-26. PubMed ID: 21315408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SCARA3 mRNA is overexpressed in ovarian carcinoma compared with breast carcinoma effusions.
    Bock AJ; Nymoen DA; Brenne K; Kærn J; Davidson B
    Hum Pathol; 2012 May; 43(5):669-74. PubMed ID: 21855113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.
    Davidson B; Lazarovici P; Ezersky A; Nesland JM; Berner A; Risberg B; Tropé CG; Kristensen GB; Goscinski M; van de Putte G; Reich R
    Clin Cancer Res; 2001 Nov; 7(11):3457-64. PubMed ID: 11705863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BUB1 mRNA is significantly co-expressed with AURKA and AURKB mRNA in advanced-stage ovarian serous carcinoma.
    Davidson B; Nymoen DA; Elgaaen BV; Staff AC; Tropé CG; Kærn J; Reich R; Falkenthal TE
    Virchows Arch; 2014 Jun; 464(6):701-7. PubMed ID: 24756216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endoglin (CD105) expression in ovarian serous carcinoma effusions is related to chemotherapy status.
    Bock AJ; Tuft Stavnes H; Kærn J; Berner A; Staff AC; Davidson B
    Tumour Biol; 2011 Jun; 32(3):589-96. PubMed ID: 21350924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the 67 kDa laminin receptor and the alpha6 integrin subunit in serous ovarian carcinoma.
    Givant-Horwitz V; Davidson B; van de Putte G; Dong HP; Goldberg I; Amir S; Kristensen GB; Reich R
    Clin Exp Metastasis; 2003; 20(7):599-609. PubMed ID: 14669791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cleaved caspase-3 and nuclear factor-kappaB p65 are prognostic factors in metastatic serous ovarian carcinoma.
    Kleinberg L; Dong HP; Holth A; Risberg B; Trope' CG; Nesland JM; Flørenes VA; Davidson B
    Hum Pathol; 2009 Jun; 40(6):795-806. PubMed ID: 19157506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different expression and clinical role of S100A4 in serous ovarian carcinoma at different anatomic sites.
    Maelandsmo GM; Flørenes VA; Nguyen MT; Flatmark K; Davidson B
    Tumour Biol; 2009; 30(1):15-25. PubMed ID: 19194111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AZGP1 and SPDEF mRNA expression differentiates breast carcinoma from ovarian serous carcinoma.
    Stavnes HT; Nymoen DA; Langerød A; Holth A; Børresen Dale AL; Davidson B
    Virchows Arch; 2013 Feb; 462(2):163-73. PubMed ID: 23242172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyaluronan synthase and hyaluronidase expression in serous ovarian carcinoma is related to anatomic site and chemotherapy exposure.
    Weiss I; Trope CG; Reich R; Davidson B
    Int J Mol Sci; 2012 Oct; 13(10):12925-38. PubMed ID: 23202930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications.
    Davidson B; Risberg B; Berner A; Nesland JM; Tropé CG; Kristensen GB; Bryne M; Goscinski M; van de Putte G; Flørenes VA
    Gynecol Oncol; 2001 Nov; 83(2):249-56. PubMed ID: 11606079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and clinical role of chemoresponse-associated genes in ovarian serous carcinoma.
    Nymoen DA; Hetland Falkenthal TE; Holth A; Ow GS; Ivshina AV; Tropé CG; Kuznetsov VA; Staff AC; Davidson B
    Gynecol Oncol; 2015 Oct; 139(1):30-9. PubMed ID: 26232338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EphA5 protein, a potential marker for distinguishing histological grade and prognosis in ovarian serous carcinoma.
    Chen X; Wang X; Wei X; Wang J
    J Ovarian Res; 2016 Nov; 9(1):83. PubMed ID: 27887627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AlphaV- and beta1-integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients.
    Davidson B; Goldberg I; Reich R; Tell L; Dong HP; Trope' CG; Risberg B; Kopolovic J
    Gynecol Oncol; 2003 Aug; 90(2):248-57. PubMed ID: 12893184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.